Pharmaceutical preparations for the diagnosis of cancer, organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; diagnostic reagents for the diagnosis of cancer; diagnostic reagents and therapeutic reagents for the diagnosis and treatment of organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; gene therapy products, namely, engineered cell platforms for immunotherapy purposes

Pharmaceutical preparations for the diagnosis of cancer, organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; diagnostic reagents for the diagnosis of cancer; diagnostic reagents and therapeutic reagents for the diagnosis and treatment of organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; gene therapy products, namely, engineered cell platforms for immunotherapy purposes

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, engineered cells for immunotherapy purposes

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, engineered cells for immunotherapy purposes

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the diagnosis and treatment of cancer, organ transplant rejection, autoimmune and infectious diseases and autoimmune and infectious conditions; diagnostic reagents and therapeutic reagents for the diagnosis and treatment of cancer, organ transplant rejection, autoimmune and infectious diseases and autoimmune and infectious conditions